Alferon N Solution For Injection 5000000U Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Alferon N: Solution for injection (5000000U)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

INTERFERON ALFA-n3 (in ter FEER on AL fa n 3) helps the immune system fight viral infections. This medicine is used to treat genital warts, which are caused by a viral infection.

In-Depth Information

Alferon N 5,000,000unit/ml Solution for Injection

NDC: 547460001
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Condylomata Acuminata, Human Papillomavirus (HPV) Infection

Storage Information
Refrigerate (between 36 and 46 degrees F)
Protect from freezing
Alferon N 5,000,000unit/ml Solution for Injection

Reported Side Effects for Alferon N 5,000,000unit/ml Solution for Injection

Metallic Taste Incidence:
1.0%*
Severity: MILD
Onset: EARLY
Sore Throat Incidence:
1.0%*
Severity: MILD
Onset: DELAYED
Heat Intolerance Incidence:
1.0%*
Severity: MODERATE
Onset: EARLY
Hyperesthesia Incidence:
1.0%*
Severity: MODERATE
Onset: DELAYED
Bleeding Incidence:
1.0%*
Severity: MODERATE
Onset: EARLY
Extra Saliva Production Incidence:
1.0%*
Severity: MILD
Onset: EARLY
Hot Flashes Incidence:
1.0%*
Severity: MODERATE
Onset: EARLY
Rash With Pustules Incidence:
1.0%*
Severity: MILD
Onset: EARLY
Paresthesias Incidence:
1.0%*
Severity: MILD
Onset: DELAYED
Photosensitivity Incidence:
1.0%*
Severity: MILD
Onset: DELAYED
Nose Bleed Incidence:
1.0%*
Severity: MILD
Onset: DELAYED
Excessive Thirst Incidence:
1.0%*
Severity: MILD
Onset: EARLY
Painful Urination Incidence:
1.0%*
Severity: MODERATE
Onset: EARLY
Visual Impairment Incidence:
1.0-6.0%*
Severity: SEVERE
Onset: EARLY
Muscle Cramps Incidence:
1.0%*
Severity: MILD
Onset: DELAYED
Diaphoresis Incidence:
2.0-3.0%*
Severity: MILD
Onset: EARLY
Depression Incidence:
2.0-3.0%*
Severity: MODERATE
Onset: DELAYED
Itching Incidence:
2.0%*
Severity: MILD
Onset: RAPID
Inability To Sleep Incidence:
2.0%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
2.0-6.0%*
Severity: MILD
Onset: EARLY
Blurred Vision Incidence:
3.0-6.0%*
Severity: MODERATE
Onset: EARLY
Confusion Incidence:
3.0%*
Severity: MODERATE
Onset: EARLY
Joint Pain Incidence:
3.0-10.0%*
Severity: MILD
Onset: DELAYED
Vomiting Incidence:
3.0-29.0%*
Severity: MILD
Onset: EARLY
Drowsiness Incidence:
3.0-10.0%*
Severity: MILD
Onset: EARLY
Heartburn Incidence:
3.0%*
Severity: MILD
Onset: EARLY
Eye Pain Incidence:
3.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
3.0%*
Severity: MILD
Onset: EARLY
Swelling Incidence:
3.0%*
Severity: MODERATE
Onset: DELAYED
Headache Incidence:
3.0-31.0%*
Severity: MILD
Onset: EARLY
Back Pain Incidence:
4.0%*
Severity: MILD
Onset: DELAYED
Upset Stomach Incidence:
4.0-48.0%*
Severity: MILD
Onset: EARLY
Chest Pain Incidence:
6.0-10.0%*
Severity: MODERATE
Onset: EARLY
Mouth Ulcers Incidence:
6.0%*
Severity: MODERATE
Onset: DELAYED
Tired Incidence:
6.0-14.0%*
Severity: MILD
Onset: EARLY
Lightheadedness Incidence:
9.0%*
Severity: MILD
Onset: EARLY
Feeling Sick Incidence:
9.0-65.0%*
Severity: MILD
Onset: EARLY
Injection Site Reaction Incidence:
10.0%*
Severity: MILD
Onset: RAPID
Low White Blood Cell Counts Incidence:
11.0%*
Severity: MODERATE
Onset: DELAYED
Muscle Pain Incidence:
13.0-45.0%*
Severity: MILD
Onset: EARLY
Chills Incidence:
14.0-87.0%*
Severity: MILD
Onset: RAPID
Fever Incidence:
30.0-81.0%*
Severity: MILD
Onset: EARLY
Decreased Appetite Incidence:
68.0%*
Severity: MILD
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Compatible - This drug is generally safe to take by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Alferon N

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5